Chr. Hansen Holding — Proxy Solicitation & Information Statement 2016

Nov 4, 2016

Hoersholm, 2016-11-04 13:12 CET (GLOBE NEWSWIRE) --

Company announcement no. 17/2016

The Annual General Meeting of Chr. Hansen Holding A/S will take place on
Tuesday 29 November 2016 at 4:00 pm CET at the Company’s premises Boege Allé
10-12, 2970 Hoersholm, Denmark subject to the attached notice setting out the
complete wording of the proposals, which the Board of Directors intends to
table at the General Meeting.

The Board of Directors

Chr. Hansen Holding A/S

For further information, please contact:

Winnie Bügel, General Counsel & Corporate Vice President,

Compliance, Corporate Communications & Sustainability

Tel: +45 4574 7474

Anders Mohr Christensen, Senior Director, Investor Relations
Tel: +45 4574 7618

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient
solutions for the food, nutritional, pharmaceutical and agricultural
industries. The products include cultures, enzymes, probiotics and natural
colors, and all solutions are based on strong research and development
competencies coupled with significant technology investments. Revenue in the
2015/16 financial year was EUR 949 million. The company has more than 2,700
dedicated employees in 30 countries and main production facilities in Denmark,
France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on
Nasdaq Copenhagen. For further information, please visit www.chr-hansen.com.